Penguins Vaccinated Against Bird Flu

In New South Wales, Australia, a groundbreaking avian influenza vaccination program has commenced, with Taronga Zoo's little penguins, black cockatoos, emus, and owls being among the initial recipients of the H5N1 vaccine. This initiative is a critical step in safeguarding bird populations against the H5N1 virus, which has seen 16 confirmed cases across the state as of August 28, 2026. The vaccination trial, initiated this week, involves administering the vaccine to 70 animals across 18 species, with close monitoring for 14 days post-vaccination. This careful rollout aims to assess the vaccine's safety and efficacy in a broad range of species, informing future vaccination protocols.

The NSW government, through its Environment Minister Penny Sharpe, emphasized the cautious approach to the vaccine rollout, noting the importance of observing its effects on native birds. Plans are in motion to extend the vaccination to wild populations, prioritizing little penguins due to their nesting fidelity, which simplifies the logistical challenge of administering the required two doses. This effort is being coordinated with the National Parks and Wildlife Service to support vaccination of free-ranging species.

As a precautionary measure, Agriculture Minister Tara Moriarty has advised owners of backyard chickens and pet birds to enhance biosecurity. Recommendations include keeping feed and water clean and sheltered, and avoiding the use of untreated dam water. While bird flu has not been detected in commercial poultry or captive birds in Australia, and the risk to human health remains low, vigilance is paramount. The vaccine is currently licensed only for rare and endangered species, with ongoing discussions regarding potential poultry vaccination.